Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial - Goke, B; Gallwitz, B; Eriksson, J (Int J Clin Pract, 2010)
et al.